Biotech to Watch: Alnylam Pharmaceuticals Soars on Drug Data (ALNY)
July 14, 2013 at 20:39 PM EDT
Shares of Cambridge, Mass-based biotech firm Alnylam Pharmaceuticals (NASDAQ: ALNY ) soared more than 32 percent last week on the back of strong drug data in a Phase I trial. The stock has now jumped more than 174 percent in 2013 as of Friday's close and is one to
